Announcement of TTY Biopharm's unaudited income information in Feburary 2021
2021.3.10
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/03/10 | Time of announcement | 15:39:26 |
| Subject | Announcement of TTY Biopharm's unaudited income information in Feburary 2021 | ||||
| Date of events | 2021/03/10 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/03/10 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $258,866 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $42,624 thousands, and a consolidated income before tax of $45,143 thousands in Feburary 2021; net income attributed to stockholders of the company was $35,946 thousands; EPS is $0.14. Year-to-date consolidated net sales was $641,772 thousands (in NT dollars; unaudited), a consolidated operating profit was $154,872 thousands and consolidated income before tax was $164,862 thousands until Feburary 2021; year-to-date net income attributed to stockholders of the company was $131,795 thousands; EPS is $0.53. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||